Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
jghn
on July 9, 2021
|
parent
|
context
|
favorite
| on:
Death rates are declining for many common cancers ...
Exactly. Insurance companies are very interested in Real World Data (RWD) around genomic based treatments. By using those data they can have a better sense of which patients would be likely to respond to which drugs, and steer treatment that way.
Gibbon1
on July 9, 2021
[–]
There another reason for genomic tests they also rule out the need for treatment. Either the tumor is benign or very low grade cancer.
Join us for
AI Startup School
this June 16-17 in San Francisco!
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
